We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Teen Weight Control (HealthTRAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04861636
Recruitment Status : Recruiting
First Posted : April 27, 2021
Last Update Posted : April 26, 2022
Sponsor:
Collaborators:
Rhode Island Hospital
University of Oregon
Oregon Health and Science University
Information provided by (Responsible Party):
The Miriam Hospital

Brief Summary:
The prevalence of obesity in adolescents is remarkably high, with 38.7% of youth 12-15 years of age and 41.5% of 16-19 year olds meeting criteria for overweight or obesity. Behavioral weight control interventions for adolescents have had limited impact on this field and there is considerably more that needs to be done. Notably, adolescents who have difficulty managing their feelings have been found to consume higher caloric foods and report greater amounts of sedentary time. Poor emotion management among adolescents has also been associated with more rapid weight gain and higher BMI. Data from adolescents with overweight/obesity attending our outpatient weight management program (N=124) indicate that 82% of these youth report emotion regulation scores that are comparable to youth with significant mental health problems. Despite documented relationships between adolescent weight control and emotion regulation, no proven adolescent weight management programs targeting emotion regulation exist. To fill this gap, our laboratory developed and piloted an adolescent weight control intervention (HealthTRAC) that combines two previously tested effective interventions, one targeting emotion regulation skill building, the other focused on behavioral weight control. Findings from our small pilot trial are promising and indicate that the newly created HealthTRAC intervention is acceptable to parents and teens, easy to deliver, and leads to modest weight loss and improved emotion management skills compared to a standard behavioral weight control (SBWC) program. These data suggest that emotion regulation is related to weight management and may assist adolescents with overweight/obesity who are seeking to lose weight. The current multi-site study builds on this previous work and will examine the impact of the developed HealthTRAC intervention on improving emotion regulation skills and reducing adolescent BMI in a larger sample with longer term follow-up (18 months after starting the intervention). Adolescents will receive 27.5 hours of intervention time over a 12- month period. We expect that adolescents enrolled in the HealthTRAC intervention will show greater reduction in BMI over the 12-month program and will sustain these losses up to 18 months after starting the intervention compared to teens enrolled in SBWC. The information learned from this project will help us better understand how helping adolescents manage their emotions can improve weight loss outcomes.

Condition or disease Intervention/treatment Phase
Adolescent Obesity Weight Loss Behavioral: HealthTRAC Behavioral: SBWC Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Both the standard behavioral weight control (SBWC) and HealthTRAC interventions include 4 months of intensive treatment, followed by monthly maintenance sessions for a 12-month program. SBWC includes attention to diet and activity coupled with behavioral modification strategies. HealthTRAC integrates these key constructs with an emotion regulation intervention with documented efficacy in teens.
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Enhancing Emotion Regulation to Support Weight Control Efforts in Adolescents With Overweight and Obesity
Actual Study Start Date : May 1, 2021
Estimated Primary Completion Date : August 1, 2025
Estimated Study Completion Date : August 1, 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight

Arm Intervention/treatment
Experimental: HealthTRAC
Both the standard behavioral weight control (SBWC) and HealthTRAC interventions include 4 months of intensive treatment, followed by monthly maintenance sessions for a 12-month program. SBWC includes attention to diet and activity coupled with behavioral modification strategies. HealthTRAC integrates these key constructs with an emotion regulation intervention with documented efficacy in teens.
Behavioral: HealthTRAC
Behavioral weight management intervention targeting emotion regulation skill building. Intervention components will be delivered in 27.5 hours of direct contact time across 12 months. All adolescents will be assessed prior to randomization (baseline), immediately following the intervention (4 months), upon completion of maintenance sessions (12 months) and 18 months after the start of intervention.

Active Comparator: Standard Behavioral Weight Control (SBWC)
4 months of intensive treatment focused on attention to diet and activity coupled with behavioral modification strategies, which is then followed by monthly maintenance sessions for a 12-month program.
Behavioral: SBWC
Behavioral intervention focused on behavioral weight control. Intervention components will be delivered in 27.5 hours of direct contact time across 12 months. All adolescents will be assessed prior to randomization (baseline), immediately following the intervention (4 months), upon completion of maintenance sessions (12 months) and 18 months after the start of intervention.




Primary Outcome Measures :
  1. Change in BMI from baseline to 12 months post-intervention [ Time Frame: baseline and 12 months after randomization ]
    Weight (kilograms) and height (meters^2) will be used to calculate body mass index (BMI; kg/m^2)


Secondary Outcome Measures :
  1. Examine the impact of HealthTRAC relative to SBWC on emotion regulation [ Time Frame: baseline and 4-, 12-, 18- months after randomization ]
    Completed by adolescents, DERS assesses six domains of emotion regulation on a five-point Likert scale, three of which are germane to our construct (Strategies, Impulses, and Goals). The Emotion Regulation Behaviors Scale (ERBS) assesses the use of the specific emotion regulation strategies taught in our interventions. Completed by both parents and adolescents, the Affect Dysregulation Scale (ADS) assesses the frequency of adolescents' difficulties with affect regulation. Completed by parents, the Emotion Regulation Checklist (ERC) is a measure of adolescents' emotion regulation from the perspective of the parent/caregiver. Two subscales are generated (Lability/Negativity and Emotion Regulation). Completed by adolescents, the Behavioral Indicator of Resiliency to Distress (BIRD) is a computerized distress tolerance task. This measure generates a score of total time that adolescents persist on a frustrating computerized task, which has been linked to emotion regulation abilities.

  2. Examine the impact of HealthTRAC relative to SBWC on emotional eating [ Time Frame: baseline and 4-, 12-, 18- months after randomization ]
    The Emotional Eating Scale is a 25-item self- report measure used to assess the propensity to cope with emotions by eating. Subscales include: Eating in response to anxiety, anger, and frustration (AAF), depressive symptoms (DEP), and feeling unsettled (UNS). One additional item assesses eating in response to positive affect ("happy"). For a more nuanced assessment, we will administer a 5-item assessment via secure Qualtrics link for 7 days during each assessment period. Teens will be asked to reflect on whether they experienced eating in response to any of five emotions during the course of the day. (i.e., sadness, anxiety or worry, boredom, happiness, or frustration).

  3. Examine the impact of HealthTRAC relative to SBWC on dietary intake [ Time Frame: baseline and 4-, 12-, 18- months after randomization ]
    Dietary Intake will be measured via three, non- consecutive 24-hour diet recalls. Each recall will be collected via a software program that employs a variation of the USDA's validated Multiple Pass Method to collect detailed information on each food and beverage consumed at each eating occasion over the previous 24-hour period. Data will be used to calculate Healthy Eating Index.

  4. Examine the impact of HealthTRAC relative to SBWC on physical activity and sedentary behavior [ Time Frame: baseline and 4-, 12-, 18- months after randomization ]
    Physical Activity and Sedentary Behavior will be assessed with accelerometer (ActiGraph, LLC, Pensacola FL) for a 1-week period at each of the primary assessment points.

  5. Examine the impact of HealthTRAC relative to SBWC on screen time [ Time Frame: baseline and 4-, 12-, 18- months after randomization ]
    Screen time will be assessed using 7 items derived from The Common Sense Census: Media Use by Tweens and Teens (2019). Items assess both type and amount of screen time during the previous day. This will be administered at the end of each 24-hour dietary recall interview.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   13 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

INCLUSION CRITERIA:

Participants must:

  1. be between 13 and 17 years of age
  2. have BMI greater than or equal to the 95th percentile for age and sex
  3. have a parent or guardian available to participate in the study
  4. speak English due to the group format of the intervention
  5. agree to study participation, measures, and randomization
  6. be available for long-term follow-up.

EXCLUSION CRITERIA:

Adolescents will be excluded from study participation if they:

  1. have absolute BMI greater than 50
  2. are currently involved with another weight loss program
  3. have a medical condition that would interfere with the prescribed dietary plan or participation in physical activity
  4. have a developmental delay such that the intervention materials will not be appropriate
  5. report engaging in extreme/unhealthy weight control behaviors including self-induced vomiting, laxative or diuretic use, or report a history of eating disorder, and/or are actively psychotic or suicidal at the time of screening.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04861636


Contacts
Layout table for location contacts
Contact: Wendy Hadley, PhD 541-346-2185 whadley2@uoregon.edu
Contact: Elissa Jelalian, PhD 401-793-9716 Elissa_Jelalian@brown.edu

Locations
Layout table for location information
United States, Oregon
University of Oregon Recruiting
Eugene, Oregon, United States, 97403
Contact: Wendy Hadley, PhD       whadley2@uoregon.edu   
Principal Investigator: Wendy Hadley, PhD         
Oregon Health & Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Alex Foster, MD         
Sub-Investigator: Kim Reynolds, PhD         
Principal Investigator: Alex Foster, MD         
United States, Rhode Island
The Miriam Hospital Recruiting
Providence, Rhode Island, United States, 02906
Contact: Elissa Jelalian, PhD    401-793-9716    Elissa_Jelalian@brown.edu   
Principal Investigator: Elissa Jelalian, PhD         
Sponsors and Collaborators
The Miriam Hospital
Rhode Island Hospital
University of Oregon
Oregon Health and Science University
Investigators
Layout table for investigator information
Principal Investigator: Elissa Jelalian, PhD Elissa_Jelalian@brown.edu
Layout table for additonal information
Responsible Party: The Miriam Hospital
ClinicalTrials.gov Identifier: NCT04861636    
Other Study ID Numbers: R01DK12455101
First Posted: April 27, 2021    Key Record Dates
Last Update Posted: April 26, 2022
Last Verified: April 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Pediatric Obesity
Body Weight
Weight Loss
Overnutrition
Nutrition Disorders
Overweight
Body Weight Changes